Myeloma
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Future Perspectives on the Management of Myeloma: Cure or Longterm Disease Control?
FEATURING
Roberto Magalhaes
- 38 views
- February 15, 2024
- 1
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Debates in Myeloma: Smoldering Myeloma Should NOT Be Treated
FEATURING
Evangelos Terpos
- 31 views
- February 15, 2024
- 1
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Debates in Myeloma: Smoldering Myeloma Should Be Treated
FEATURING
Claudio Cerchione
- 28 views
- February 15, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
How I Manage Late Relapsed Myeloma With T-Cell Engaging Therapy
FEATURING
Alessandra Romano
- 17 views
- February 15, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
Case Presentation: R/R Myeloma With Extramedullary Plasmacytoma Involving Optic Chiasm
FEATURING
Alpay Yeşilaltay
- 13 views
- February 15, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
MRD in the Era of Modern MM Therapies
FEATURING
Roberto Magalhaes
- 170 views
- February 15, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
How I Treat R/R MM With CAR-T and Bispecific Antibodies
FEATURING
Claudio Cerchione
- 162 views
- February 15, 2024
XIV Eurasian Hematology-Oncology Congress - EHOC 2023
IKEMA Trial Final Updates: Carfilzomib/Dex +/- Isatuximab in Patients With R/R MM
FEATURING
Ecenur Güder Arslan
- 31 views
- February 15, 2024